ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization
January 13, 2021Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS® SARS-CoV-2 Antigen Test, designed to detect active infection, has become the first high-volume COVID-19 antigen test to receive ... -
Ortho's VITROS® SARS-CoV-2 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark
October 28, 2020Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its new VITROS® SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for distribution throughout the EU.
Pharma Sources Insight January 2025
